Yang S, Fei C. Prognostic value of systemic immune-inflammation index and systemic inflammation response index for oral cancers: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2024 Nov 1;29 (6):e822-31.
doi:10.4317/medoral.26779
https://dx.doi.org/doi:10.4317/medoral.26779
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-49. |
PMid:33538338 |
2. Sun R, Dou W, Liu W, Li J, Han X, Li S, et al. Global, regional, and national burden of oral cancer and its attributable risk factors from 1990 to 2019. Cancer Med. 2023;12:13811-20. |
PMid:37132165 PMCid:PMC10315711 |
3. Valdez JA, Brennan MT. Impact of Oral Cancer on Quality of Life. Dent Clin North Am. 2018;62:143-54. |
PMid:29126491 |
4. Tranby EP, Heaton LJ, Tomar SL, Kelly AL, Fager GL, Backley M, et al. Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data. Cancer Epidemiol Biomarkers Prev. 2022;31:1849-57. |
PMid:35732291 PMCid:PMC9437560 |
5. Thavarool SB, Muttath G, Nayanar S, Duraisamy K, Bhat P, Shringarpure K, et al. Improved survival among oral cancer patients: findings from a retrospective study at a tertiary care cancer centre in rural Kerala, India. World J Surg Oncol. 2019;17:15. |
PMid:30635062 PMCid:PMC6330462 |
6. Feller L, Altini M, Lemmer J. Inflammation in the context of oral cancer. Oral Oncol. 2013;49:887-92. |
PMid:23910564 |
7. Qian S, Golubnitschaja O, Zhan X. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA J. 2019;10:365-81. |
PMid:31832112 PMCid:PMC6882964 |
8. Zheng K, Liu X, Ji W, Lu J, Cui J, Li W. The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors. J Inflamm Res. 2021;14:5769-85. |
PMid:34764670 PMCid:PMC8573157 |
9. Kubota K, Ito R, Narita N, Tanaka Y, Furudate K, Akiyama N, et al. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment. BMC Cancer. 2022;22:368. |
PMid:35392843 PMCid:PMC8991673 |
10. Lin J, Chen L, Chen Q, Zhuang Z, Bao X, Qian J, et al. Prognostic value of preoperative systemic inflammation response index in patients with oral squamous cell carcinoma: Propensity score-based analysis. Head Neck. 2020;42:3263-74. |
PMid:32681711 |
11. He K, Si L, Pan X, Sun L, Wang Y, Lu J, et al. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery. Front Oncol. 2022;12:829689. |
PMid:35296020 PMCid:PMC8918673 |
12. Jiang L, Fang J, Ding J. High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab. Cancer Manag Res. 2020;12:475-84. |
PMid:32021460 PMCid:PMC6982528 |
13. Jiang Y, Xu D, Song H, Qiu B, Tian D, Li Z, et al. Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis. BMJ Open. 2021;11:e048324. |
PMid:34593492 PMCid:PMC8487212 |
14. Ren JY, Xu M, Niu XD, Ma SX, Jiao YJ, Wang D, et al. Systemic inflammatory response index is a predictor of prognosis in gastric cancer patients: Retrospective cohort and meta-analysis. World J Gastrointest Surg. 2024;16:382-95. |
PMid:38463377 PMCid:PMC10921201 |
15. Wang L, Qin X, Zhang Y, Xue S, Song X. The prognostic predictive value of systemic immune index and systemic inflammatory response index in nasopharyngeal carcinoma: A systematic review and meta-analysis. Front Oncol. 2023;13:1006233. |
PMid:36816962 PMCid:PMC9936064 |
16. Zhang S, Cheng T. Prognostic and clinicopathological value of systemic inflammation response index (SIRI) in patients with breast cancer: a meta-analysis. Ann Med. 2024;56:2337729. |
PMid:38569199 PMCid:PMC10993763 |
17. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. |
PMid:33789826 |
18. Hayden JA, Côté P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006;144:427-37. |
PMid:16549855 |
19. Diao P, Wu Y, Li J, Zhang W, Huang R, Zhou C, et al. Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection. J Transl Med. 2018;16:365. |
PMid:30563540 PMCid:PMC6299596 |
20. Valero C, Zanoni DK, McGill MR, Ganly I, Morris LGT, Quer M, et al. Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer. Cancer. 2020;126:994-1003. |
PMid:31809562 PMCid:PMC7971350 |
21. Lu Z, Yan W, Liang J, Yu M, Liu J, Hao J, et al. Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection. Front Oncol. 2020;10:341. |
PMid:32219070 PMCid:PMC7078378 |
22. Erdiş E, Yücel B. Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Tumors. ENT Updat. 2020. |
PMid: |
23. Wei LF, Huang XC, Lin YW, Luo Y, Ding TY, Liu CT, et al. A Prognostic Model Based on Clinicopathological Features and Inflammation- and Nutrition-Related Indicators Predicts Overall Survival in Surgical Patients With Tongue Squamous Cell Carcinoma. Technol Cancer Res Treat. 2021;20:15330338211043048. |
PMid:34866500 PMCid:PMC8652185 |
24. Nie Z, Zhao P, Shang Y, Sun B. Nomograms to predict the prognosis in locally advanced oral squamous cell carcinoma after curative resection. BMC Cancer. 2021;21:372. |
PMid:33827452 PMCid:PMC8028060 |
25. Hung SP, Chen PR, Ho TY, Chang KP, Chou WC, Lee CH, et al. Prognostic significance of the preoperative systemic immune-inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapy. Cancer Med. 2021;10:649-58. |
PMid:33325655 PMCid:PMC7877364 |
26. Song F, Cai H, Liao Y, Huang S, Jiang Y, Liang J, et al. The systemic inflammation response index predicts the survival of patients with clinical T1-2N0 oral squamous cell carcinoma. Oral Dis. 2022;28:600-10. |
PMid:33486833 |
27. Zakaria SS, Ramanathan A, Mat Ripen Z, Ghani WMN, Yang YH, Vincent-Chong VK, et al. Prognostic Abilities of Pre- and Post-Treatment Inflammatory Markers in Oral Squamous Cell Carcinoma: Stepwise Modelling. Medicina (Kaunas). 2022;58:1426. |
PMid:36295584 PMCid:PMC9606996 |
28. Ruiz-Ranz M, Lequerica-Fernández P, Rodríguez-Santamarta T, Suárez-Sánchez FJ, López-Pintor RM, García-Pedrero JM, et al. Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment. Front Immunol. 2022;13:941351. |
PMid:35958590 PMCid:PMC9360320 |
29. Huang CH, Lue KH, Chen PR, Hsieh TC, Chou YF. Association between Sarcopenia and Immediate Complications and Mortality in Patients with Oral Cavity Squamous Cell Carcinoma Undergoing Surgery. Cancers (Basel). 2022;14:785. |
PMid:35159050 PMCid:PMC8833832 |
30. Cho U, Sung YE, Kim MS, Lee YS. Prognostic Role of Systemic Inflammatory Markers in Patients Undergoing Surgical Resection for Oral Squamous Cell Carcinoma. Biomedicines. 2022;10:1268. |
PMid:35740290 PMCid:PMC9220324 |
31. Trevisani LFM, Kulcsar IF, Kulcsar MAV, Dedivitis RA, Kowalski LP, Matos LL. Prognostic Value of Hematological Parameters in Oral Squamous Cell Carcinoma. Cancers (Basel). 2023;15:5245. |
PMid:37958419 PMCid:PMC10649982 |
32. Cheng H, Xu JH, He JQ, Yang XY, Shen XN, Xu XL. Multivariate analysis of prognostic factors in patients with lip squamous cell carcinoma after surgery. World J Surg Oncol. 2024;22:35. |
PMid:38279138 PMCid:PMC10811904 |
33. Su J, Wang X, Sun Z. [Establishment and verification of a prognostic nomogram for survival of tongue squamous cell carcinoma patients who underwent cervical dissection]. Beijing Da Xue Xue Bao. 2024;56:120-30. |
PMid:38318906 |
34. Zhang J, Dai S. Prognostic and clinicopathological role of pretreatment systemic immune-inflammation index in patients with oral squamous cell carcinoma: a meta-analysis. Front Oncol. 2023;13:1303132. |
PMid:38293698 PMCid:PMC10824905 |
35. Qiu Y, Zhang Z, Chen Y. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis. Front Oncol. 2021;11:33777726. |
PMid:33777726 PMCid:PMC7990885 |
36. Wang Q, Zhu SR, Huang XP, Liu XQ, Liu JB, Tian G. Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: A meta-analysis. Eur Rev Med Pharmacol Sci. 2021;25:1302-10. |
PMid:33629300 |
37. Zeng Z, Xu S, Wang D, Qin G. Prognostic significance of systemic immune-inflammation index in patients with nasopharyngeal carcinoma: a meta-analysis. Syst Rev. 2022;11:247. |
PMid:36403072 PMCid:PMC9675963 |
38. Sano Y, Kogashiwa Y, Araki R, Enoki Y, Ikeda T, Yoda T, et al. Correlation of Inflammatory Markers, Survival, and COX2 Expression in Oral Cancer and Implications for Prognosis. Otolaryngol Head Neck Surg. 2018;158:667-76. |
PMid:29359615 |
39. Wu L, Saxena S, Singh RK. Neutrophils in the Tumor Microenvironment. Adv Exp Med Biol. 2020;1224:1-20. |
PMid:32036601 PMCid:PMC7325741 |
40. Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493-503. |
PMid:25281468 |